These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23564776)

  • 1. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
    Shishido Y; Ueno S; Yamazaki R; Nagaoka M; Matsuzaki T
    Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
    Yamazaki R; Nishiyama Y; Furuta T; Hatano H; Igarashi Y; Asakawa N; Kodaira H; Takahashi H; Aiyama R; Matsuzaki T; Yagi N; Sugimoto Y
    Mol Cancer Ther; 2011 Jul; 10(7):1252-63. PubMed ID: 21566063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
    Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
    Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
    Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.
    Katayama R; Koike S; Sato S; Sugimoto Y; Tsuruo T; Fujita N
    Cancer Sci; 2009 Nov; 100(11):2060-8. PubMed ID: 19673889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
    Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Kawano T; Yonezawa H; Rokutanda S; Naruse T; Umeda M
    Oral Oncol; 2011 Sep; 47(9):855-60. PubMed ID: 21757396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
    Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
    Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
    Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma.
    Yashiro M; Nishii T; Hasegawa T; Matsuzaki T; Morisaki T; Fukuoka T; Hirakawa K
    Br J Cancer; 2013 Nov; 109(10):2619-28. PubMed ID: 24129235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of the combination between cytotoxic drug and efflux transporter inhibitors based on a tumour growth inhibition model.
    Sostelly A; Payen L; Guitton J; Di Pietro A; Falson P; Honorat M; Boumendjel A; Gèze A; Freyer G; Tod M
    Fundam Clin Pharmacol; 2014 Apr; 28(2):161-9. PubMed ID: 23384250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scutellaria extract decreases the proportion of side population cells in a myeloma cell line by down-regulating the expression of ABCG2 protein.
    Lin MG; Liu LP; Li CY; Zhang M; Chen Y; Qin J; Gu YY; Li Z; Wu XL; Mo SL
    Asian Pac J Cancer Prev; 2013; 14(12):7179-86. PubMed ID: 24460272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
    Mishra MN; Vangara KK; Palakurthi S
    Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.
    Dou J; Jiang C; Wang J; Zhang X; Zhao F; Hu W; He X; Li X; Zou D; Gu N
    Cell Biol Int; 2011 Mar; 35(3):227-34. PubMed ID: 21108606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice.
    Stewart CF; Leggas M; Schuetz JD; Panetta JC; Cheshire PJ; Peterson J; Daw N; Jenkins JJ; Gilbertson R; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2004 Oct; 64(20):7491-9. PubMed ID: 15492275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
    Xie ZY; Lv K; Xiong Y; Guo WH
    Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
    Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells.
    Hu J; Li J; Yue X; Wang JC; Wang JF; Liu JZ; Kong DL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):231-236. PubMed ID: 28397046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
    Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
    Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.